Advancing Vision Research, LLC — research payments reported

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$133,280	6
2023	Research	$492,515	7
2021	Research	$36,466	4
2020	Research	$36,725	4

Breakdown

Who paid Research payments · program years 2020–2025

Bausch & Lomb Americas Inc. $622,585 10 payments
Bausch Health US, LLC $73,191 8 payments
Oyster Point Pharma, Inc. $3,210 3 payments

Studies the money was for Research payments · program years 2020–2025

A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled Evaluation of the Onset and Duration of Action of the Combination Drug Product Brimonidine Tartrate 0.025% / Ketotifen Fumarate 0.035% Ophthalmic Solution Compared to its Components and Vehicle in an Allergen BioCube (ABC) Clinical Trial in Subjects with Seasonal Allergic Conjunctivitis $492,515 7 payments
A Randomized, Multicenter, Double-Masked, Active-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness $130,070 3 payments
A Phase 3, Multi-Center, Randomized, Double- Masked, Saline-Controlled Trial to Evaluate the Effect of NOV03 (Perfluorohexyloctane) on Signs and Symptoms of Dry Eye Disease Associated with Meibomian Gland Dysfunction (GOBI) $68,810 5 payments
A Phase 3, Multi-Center, Open-Label, Single-Arm Extension Clinical Trial to Assess the Extended Long-Term Safety and Tolerability of NOV03 (Perfluorohexyloctane) in Subjects who Completed Trial NVU-003 (SEECASE-2 OLE) $4,381 3 payments
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (LYNX-3) $3,210 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.